口咽癌术后30天非计划再入院率、原因及危险因素分析
基于美国全国再入院数据库2010至2014年16,902例口咽癌手术患者,30天非计划再入院率为10.2%,平均每次再入院费用14,170美元;术后出血(14.1%)和伤口并发症(12.6%)是最常见原因。多因素回归显示,大范围切除手术、Charlson/Deyo合并症高分、放疗史、Medicare或Medicaid支付身份、急诊入院及住院≥6天为独立危险因素。
要点
- 口咽癌术后约十分之一患者30天内非计划再入院,术后出血与伤口并发症为主因。
- 大范围切除手术、晚期合并症、放疗史、医保支付身份及住院≥6天增加再入院风险。
- 围手术期应重点防控出血与伤口并发症,并关注高危支付身份与合并症患者。
核心结论
- 口咽癌手术后约10.2%的患者在30天内非计划再入院,手术复杂度、保险状态和晚期合并症是独立危险因素。
研究设计与样本
- 回顾性队列研究,分析美国全国再入院数据库2010至2014年16,902例口咽癌手术患者。
- 采用多因素logistic回归识别30天非计划再入院的危险因素,证据等级为4级。
主要发现
- 30天非计划再入院率为10.2%,平均每次再入院费用为14,170美元。
- 最常见再入院诊断为术后出血(14.1%)和伤口并发症(12.6%),其中手术部位感染8.6%、伤口裂开2.3%、瘘1.7%。
- 大范围切除手术(含全舌切除、咽切除、下颌骨切除)OR为1.29(95%CI 1.06-1.60)。
- Charlson/Deyo合并症高分OR为2.00(95%CI 1.43-2.79),放疗史OR为1.58(95%CI 1.15-2.17)。
- Medicare支付OR为1.34(95%CI 1.06-1.69),Medicaid支付OR为1.82(95%CI 1.32-2.50);急诊入院OR为1.19(95%CI 1.02-1.40);住院≥6天OR为1.57(95%CI 1.19-2.08)。
临床怎么用
- 对接受大范围切除、合并症重、有放疗史及Medicare/Medicaid支付的口咽癌手术患者,应加强术后出血和伤口并发症的监测与出院计划。
局限性
- 本研究为回顾性数据库分析,证据等级为4级,可能存在编码与未测混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Determine the rate, diagnoses, and risk factors associated with 30-day nonelective readmissions for patients undergoing surgery for oropharyngeal cancer. STUDY DESIGN: Retrospective cohort study. METHODS: We analyzed the Nationwide Readmissions Database for patients who underwent oropharyngeal cancer surgery between 2010 and 2014. Rates and causes of 30-day readmissions were determined. Multivariate logistic regression was used to identify risk factors for readmission. RESULTS: Among 16,902 identified cases, the 30-day, nonelective readmission rate was 10.2%, with an average cost per readmission of $14,170. The most common readmission diagnoses were postoperative bleeding (14.1%) and wound complications (12.6%) (surgical site infection [8.6%], dehiscence [2.3%], and fistula [1.7%]). On multivariate regression, significant risk factors for readmission were major ablative surgery (which included total glossectomy, pharyngectomy, and mandibulectomy) (odds ratio [OR]: 1.29, 95% confidence interval [CI]: 1.06-1.60), advanced Charlson/Deyo comorbidity (OR: 2.00, 95% CI: 1.43-2.79), history of radiation (OR: 1.58, 95% CI: 1.15-2.17), Medicare (OR: 1.34, 95% CI: 1.06-1.69) or Medicaid (OR: 1.82, 95% CI: 1.32-2.50) payer status, index admission from the emergency department (OR: 1.19, 95% CI: 1.02-1.40), and length of stay ≥6 days (OR: 1.57, 95% CI: 1.19-2.08). CONCLUSIONS: In this large database analysis, we found that approximately one in 10 patients undergoing surgery for oropharyngeal cancer is readmitted within 30 days. Procedural complexity, insurance status, and advanced comorbidity are independent risk factors, whereas postoperative bleeding and wound complications are the most common reasons for readmission. LEVEL OF EVIDENCE: 4. Laryngoscope, 129:910-918, 2019.
引用
- Goel AN, Badran KW, Mendelsohn AH, et al. Readmission after surgery for oropharyngeal cancer: An analysis of rates, causes, and risk factors. Laryngoscope. 2018. PMID: 30229931. doi:10.1002/lary.27461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。